Skip to main content
SpringerLink
Log in

The Cephalosporins: Activity and Clinical Use

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The cephalosporin antibiotics have been employed with increasing frequency since their introduction into clinical practice in the early 1960s. With the exception of cephaloridine, cephalosporin compounds are not associated with the production of significant untoward effects. The availability of newer cephalosporins, both oral and parenteral, with enhanced antibacterial activity, has expanded the clinical indications for administration of these antibiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abraham, E.P.: The cephalosporins. Pharmacological Reviews 14: 473–500 (1971).

    Google Scholar 

  • Abraham, E.P. and Newton, C.C.F.: New penicillins, cephalosporin C, and penicillinase. Endeavour 20: 92–100 (1961).

    PubMed  CAS  Google Scholar 

  • Abraham, B.N.; Petz, L.D.; and Fudenberg, H.H.: Immunohaematological cross-allergenicity between penicillin and cephalothin in humans. Clinical and Experimental Immunology 3: 343–357 (1968).

    PubMed  CAS  Google Scholar 

  • Actor, P.; Pitkin, D.H.; Lucyszyn, G.; Weisbach, J.A. and Bran, J.L.: Cefatrizine (SKF 60771), a new oral cephalosporin: Serum levels and urinary recovery in humans after oral or intramuscular administration — comparative study with cephalexin and cefazolin. Antimicrobial Agents and Chemotherapy 9: 800–803 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Appelstein, J.M.; Crosby, E.B.; Johnson, W.D. and Kaye, D.: In vitro antimicrobial activity and human pharmacology of cephaloglycin. Applied Microbiology 16: 1006–1010 (1968).

    Google Scholar 

  • Axelrod, J.; Meyers, B.R. and Hirschman, S.Z.: Cephapirin: in vitro antibacterial spectrum. Applied Microbiology 22: 904–908 (1971).

    PubMed  CAS  Google Scholar 

  • Barza, M.; Tally, F.P.; Jacobus, N.V. and Gorbach, S.L.: In vitro activity of LY127935. Antimicrobial Agents and Chemotherapy 16: 287–292(1979).

    Article  PubMed  CAS  Google Scholar 

  • Bassaris, H.P.; Quintiliani, R.; Maderazo, E.G.; Tilton, R.C. and Nightingale, C.H.: Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid. Current Therapeutic Research 19: 110–120 (1976).

    PubMed  CAS  Google Scholar 

  • Batchelor, F.R.; Dewdney, J.M. and Gazzard, D.: Penicillin allergy: The formation of the penicilloyl determinant. Nature (London) 206: 362–364 (1965).

    Article  CAS  Google Scholar 

  • Bax, R.P.; Dawson, A.F.; Mullinger, B.M. and Dash, C.H.: Cefuroxime in the treatment of lower respiratory tract infection. Current Medical Research and Opinion 5: 772–778 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Berg, S.W.; Kilpatrick, M.E.; Harrison, W.O. and McCutchan, J.A.: Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae. New England Journal of Medicine 301: 509–511 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Bill, N.J. and Washington, J.A. II: Comparison of in vitro activity of cephalexin, cephradine, and cefaclor. Antimicrobial Agents and Chemotherapy 11: 470–474 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Bodey, G.P. and Weaver, S.: In vitro studies of cefamandole. Antimicrobial Agents and Chemotherapy 9: 452–457 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Brandriss, M.W.; Smith, J.W.and Steinman, H.G.: Common antigenic determinants of penicillin G, cephalothin and 6-aminopenicillanic acid in rabbits. Journal of Immunology 94: 696–704 (1965).

    CAS  Google Scholar 

  • Brorson, J.E. and Norrby, R.: Comparative in vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin. Scandinavian Journal of Infectious Diseases 13 (Suppl.) 88–93 (1978).

    PubMed  CAS  Google Scholar 

  • Bryant, R.E. and Alford, R.H.: Unsuccessful treatment of staphylococcal endocarditis with cefazolin. Journal of the American Medical Association 237: 569–570 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Buck, R.E. and Price, K.E.: Cefadroxil, a new broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 11: 324–330 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Burdash, N.M.; Ehrlich, M.A.; Ehrlich, H.G. and Parisi, J.T.: Electron microscopy of Proteus vulgaris exposed to cephalothin. Journal of Bacteriology 95: 1956–1960 (1968).

    PubMed  CAS  Google Scholar 

  • Carrizosa, J.; Levison, M.E. and Kaye, D.: Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin. Antimicrobial Agents and Chemotherapy 3: 306–307 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Chang, T.W. and Weinstein, L.: In vitro biological activity of cephalothin. Journal of Bacteriology 85: 1022–1027 (1963).

    PubMed  CAS  Google Scholar 

  • Chang, T.W. and Weinstein, L.: Inhibition of synthesis of the cell wall of Staphylococcus aureus by cephalothin. Science 143: 807–808 (1964a).

    Article  PubMed  CAS  Google Scholar 

  • Chang, T.W. and Weinstein, L.: Morphological changes in Gramnegative bacilli exposed to cephalothin. Journal of Bacteriology 88: 1790–1797 (1964b).

    PubMed  CAS  Google Scholar 

  • Chisholm, D.R.; Leitner, F.; Misiek, M.; Wright, G.E. and Price, K.D.: Laboratory studies with a new cephalosporanic acid derivative. Antimicrobial Agents and Chemotherapy 244–246 (1969).

  • Cole, D.R. and Pung, J.: Penetration of cefazolin into pleural fluid. Antimicrobial Agents and Chemotherapy 11: 1033–1035 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Cordero, A.: Treatment of soft tissue infections with cefadroxil, a new oral cephalosporin. Journal of International Medical Research 4: 176–178 (1976).

    PubMed  CAS  Google Scholar 

  • Cunha, B.A.; Gossling, H.R.; Pasternak, H.S.; Nightingale, C.H. and Quintiliani, R.: The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. Journal of Bone and Joint Surgery 59A: 856–859(1977).

    Google Scholar 

  • Cunha, B.A.; Klimek, J.; Nightingale, C. and Quintiliani, R.: Clinical evaluation of cefamandole in lower respiratory and urinary tract infections. Current Therapeutic Research 25: 584–589 (1979).

    Google Scholar 

  • Currie, J.P.: Cephaloridine: Pharmacology and toxicology. Postgraduate Medical Journal 43 (Suppl.): 22–26 (1967).

    PubMed  CAS  Google Scholar 

  • Delgado, D.G.; Brau, C.J.; Cobbs, C.G. and Dismukes, W.E.: Clinical and laboratory evaluation of cefamandole in the therapy of Haemophilus species bronchopulmonary infections. Antimicrobial Agents and Chemotherapy 15: 807–812 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Eickhoff, T.C. and Ehret, J.M.: In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin. Antimicrobial Agents and Chemotherapy 9: 994–999 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Fass, R.J. and Prior, R.B.: Comparative in vitro activities of oral cephalosporins and competitive antibiotics against recent clinical isolates. Current Therapeutic Research 24: 352–365 (1978).

    CAS  Google Scholar 

  • Flemming, P.C. and Jaffe, D.: The nephrotoxic effect of cephaloridine. Postgraduate Medical Journal 43 (Suppl): 89–90 (1967).

    Google Scholar 

  • Friedrich, H.; Pelz, K. and Hansel-Friedrich, G.: Lack of penetration of cephacetril into the cerebrospinal fluid of patients without meningitis. Infection 7: 41–44 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Fu, K.P.; Aswapokee, P.; Ho, I.; Matthijssen, C. and Neu, H.C.: Pharmacokinetics of cefotaxime. Antimicrobial Agents and Chemotherapy 16: 592–597 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Gardner, J.C.; Price, T.M.L. and Southwell, N.: Cephaloridine in the treatment of urmary proteus infections. Lancet 2: 725–727 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Geddes, A.M.; McGhie, D.; Ball, A.P. and Gould, I.: Studies with cefuroxime and cefoxitin. Scandinavian Journal of Infectious Diseases 13 (Suppl.): 78–81 (1978).

    PubMed  CAS  Google Scholar 

  • Gralnick, H.R. and McGinniss, M.H.: Immune cross-reactivity of penicillin and cephalothin. Nature (London) 216: 1026–1027 (1967).

    Article  CAS  Google Scholar 

  • Gralnick, H.R.; Wright, L.D. Jr. and McGinniss, M.H.: Coombs’ positive reactions associated with sodium cephalothin therapy. Journal of the American Medical Association 199: 725–726 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Griffith, R.S. and Black, H.R.: Cephalothin — a new antibiotic. Journal of the American Medical Association 189: 823–828 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Griffith, R.S.and Black, H.R.: Cephalexin: A new antibiotic. Clinical Medicine 75: 14–22 (1968).

    CAS  Google Scholar 

  • Henness, D.M.; Richards, D.; Santella, P.J. and Rubinfeld, J.: Oral bioavailability of cefadroxil, a new semisynthetic cephalosporin. Clinical Therapeutics 1: 263–273 (1978).

    CAS  Google Scholar 

  • Inagaki, J. and Bodey, G.P.: Phlebitis associated with cephalosporins: Cephapirin versus cephalothin. Current Therapeutic Research 15: 37–43(1973).

    PubMed  CAS  Google Scholar 

  • Investigational Manual, LY127935, Eli Lilly and Company, Indianapolis, Indiana, USA (1979).

  • Johnson, W.D.; Applestein, J.M. and Kaye, D.: Cephaloglycin: Clinical and laboratory experience with an orally administered cephalosporin. Journal of the American Medical Association 206: 2698–2702 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Jones, R.N. and Fuchs, P.C.: Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 9: 1066–1069 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Jones, R.N.; Fuchs, P.C.; Gavan, T.L.; Gerlach, E.H.; Barry, A.L. and Thornsberry, C: Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 12: 47–50 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Jones, R.N.; Fuchs, P.C.; Thornsberry, C.; Barry, A.L.; Gavan, T.L. and Gerlach, E.H.: Cefaclor and cefatrizine, new investigational orally administered cephalosporins — in vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics. American Journal of Clinical Pathology 72: 578–585 (1979).

    PubMed  CAS  Google Scholar 

  • Kabins, S.A. and Cohen, S.: Cephalothin serum levels in the azotemic patient. Antimicrobial Agents and Chemotherapy 4: 207–214 (1964).

    Google Scholar 

  • Kabins, S.A. and Cohen, S.: Cephaloridine therapy as related to renal function. Antimicrobial Agents and Chemotherapy 5: 922–932 (1965).

    PubMed  CAS  Google Scholar 

  • Kaiser, G.V.; Gorman, M.and Webber, J.A.: Cefamandole — a review of chemistry and microbiology. Journal of Infectious Diseases 137 (Suppl.): S10–16 (1978).

    Article  PubMed  Google Scholar 

  • Kammer, R.B. and Short, L.J.: Cefaclor — summary of clinical experience. Postgraduate Medical Journal 55 (Suppl.): 93–97 (1979).

    PubMed  Google Scholar 

  • Kaplan, K.; Reisberg, B.E. and Weinstein, L.: Cephaloridine: antimicrobial activity and pharmacologic behavior. American Journal of Medical Sciences 253: 667–674 (1967).

    Article  CAS  Google Scholar 

  • Klein, J.L.; Eickhoff, T.C.; Tilles, J.G. and Finland, M.: Cephalothin: Activity in vitro, absorption and excretion in normal subjects and clinical observations in 40 patients. American Journal of Medical Sciences 248: 640–656 (1964).

    Article  CAS  Google Scholar 

  • Klimek, J.J.; Nightingale, C. and Quintiliani, R.: Penetration of cephalosporin antibiotics into human atrial appendage tissue in patients undergoing open-heart surgery (abstract). Sixteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, pp. 27–29 (1976).

  • Knusel, F.; Konopka, E.A.; Geizer, J. and Rosselet, A.: Antimicrobial studies in vitro with CIBA 36278-Ba, a new cephalosporin derivative. Antimicrobial Agents and Chemotherapy 140–149 (1970).

  • Kunin, C.M. and Brandt, D.: Comparative studies of ampicillin, cephalothin and a new cephalosporin derivative, cephaloglycin. American Journal of Medical Sciences 255: 196–201 (1968).

    Article  CAS  Google Scholar 

  • Lambin, S. and Bernard, J.: Mode of action in vitro of cephaloridine against Staphylococcus aureus and Escherichia coli. Postgraduate Medical Journal 43 (Suppl.): 42–46 (1967).

    PubMed  CAS  Google Scholar 

  • Landes, R.R.; McCormick, B.; Graham, R.; Melnick, I. and Brown, D.: Cephaloridine therapy for genitourinary infections. Southern Medical Association 60: 311–316 (1967).

    CAS  Google Scholar 

  • Levinson, M.E.; Johnson, W.D.; Thornhill, T.S. and Kaye, D.: Clinical and in vitro evaluation of cephalexin. Journal of the American Medical Association 209: 1331–1336 (1969).

    Article  Google Scholar 

  • Levison, M.E.; Santoro, J. and Agarwal, B.N.: In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure. Postgraduate Medical Journal 55 (Suppl. 4): 12–16 (1979).

    PubMed  CAS  Google Scholar 

  • Lode, H.; Stahlmann, R. and Koeppe, P.: Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000. Antimicrobial Agents and Chemotherapy 16: 1–6 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Low, R.A.L. and Clarke, T.K.: Cephradine in urinary tract infections: A double-blind comparison with ampicillin. Current Medical Research and Opinion 3: 211–217 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Luthy, R.; Munch, R.; Blaser, J.; Bhend, H. and Siegenthaler, W.: Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrobial Agents and Chemotherapy 16: 127–133 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Mangi, R.J., Kundargi, R.S.; Quintiliani, R. and Andriole, V.T.: Development of meningitis during cephalothin therapy. Annals of Internal Medicine 78: 347–351 (1973).

    PubMed  CAS  Google Scholar 

  • Meyers, B.R.; Kaplan, K. and Weinstein, L.: Cephalexin: Microbiological effects and pharmacologic parameters in man. Clinical Pharmacology and Therapeutics 10: 810–816 (1969).

    PubMed  CAS  Google Scholar 

  • Meyers, B.R.; Leng, B. and Hirschman, S.Z.: Cefamandole: Antimicrobial activity in vitro of a new cephalosporin. Antimicrobial Agents and Chemotherapy 8: 737–741 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Mirrett, S. and Relier, L.B.: Comparative activity in vitro of cefaclor, cephalexin, and cephradine. Current Therapeutic Research 26: 145–151 (1979).

    CAS  Google Scholar 

  • Moellering, R.C., Jr.: Cefamandole — a new member of the cephalosporin family. Journal of Infectious Diseases 137 (Suppl.): S2–S9 (1978).

    Article  PubMed  Google Scholar 

  • Moellering, R.C., Jr. and Swartz, M.N.: The newer cephalosporins. New England Journal of Medicine 294: 24–28 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Molthan, L.; Reidenberg, M.M. and Eichman, M.F.: Positive direct Coombs’ tests due to cephalothin. New England Journal of Medicine 277: 123–125 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Mouallem, R.: Comparative efficacy and safety of cephradine and cephalexin in children. Journal of International Medical Research 4: 265–271 (1976).

    PubMed  CAS  Google Scholar 

  • Muggleton, P.W.; O’Callaghan, C.H.; Foord, R.D.; Kirby, S.M. and Ryan, D.M.: Laboratory appraisal of cephalexin. Antimicrobial Agents and Chemotherapy A 353–360 (1968).

  • Neu, H.C.: Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. Journal of Infectious Diseases 137 (Suppl.): S80–S87 (1978).

    Article  PubMed  Google Scholar 

  • Neu, H.C.; Aswapokee, N.; Fu, K.P. and Aswapokee, P.: Antibacterial activity of a new 1 -oxa cephalosporin compared with that of other β-lactam compounds. Antimicrobial Agents and Chemotherapy 16: 141–149 (1979a).

    Article  PubMed  CAS  Google Scholar 

  • Neu, H.C.; Fu, K.P.; Aswapokee, N.; Aswapokee, P. and Kung, K.: Comparative activity and β-lactamase stability of cefoperazone, a piperazine cephalosporin. Antimicrobial Agents and Chemotherapy 16: 150–157 (1979b).

    Article  PubMed  CAS  Google Scholar 

  • Neu, H.C. and Winshell, E.B.: In vitro evaluation of cephacetrile, a new cephalosporin antibiotic. Journal of Antibiotics 25: 400–404 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Nightingale, C.H.; Greene, D.S. and Quintiliani, R.: Pharmacokinetics and clinical use of cephalosporin antibiotics. Journal of Pharmaceutical Sciences 64: 1899–1927 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Oller, L.Z.: Cephaloridine in gonorrhoeae and syphilis. British Journal of Venereal Diseases 43: 39–47 (1967a).

    Google Scholar 

  • Oller, L.Z.: Cephaloridine in early syphilis. Postgraduate Medical Journal 43 (Suppl.): 128–129 (1967b).

    PubMed  Google Scholar 

  • Parker, C.W.: Penicillin allergy. American Journal of Medicine 34: 747–749 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Parry, M.F.; Goldberger, M.J. and Neu, H.C.: Therapy of serious infections with cefamandole. Infection 6: 236–240 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Perkins, R.L.; Apicella, M.A.; Lee, I.; Cuppage, F.E. and Saslaw, S.: Cephaloridine and cephalothin: Comparative studies of potential nephrotoxicity. Journal of Laboratory and Clinical Medicine 71: 75–84 (1968).

    PubMed  CAS  Google Scholar 

  • Perkins, R.L.; Saslaw, S. and Hackett, J.: Cephaloridine and cephalothin comparative in vitro evaluation. American Journal of Medical Sciences 253: 293–299 (1967).

    Article  CAS  Google Scholar 

  • Perkins, R.L.; Slama, T.G.; Fass, R.J.; Prior, R.B.; Plouffe, J.F.; Warner, J.F. and File, T.M.: Therapy of skin, soft tissue, and bone infections with cefoxitin sodium. Review of Infectious Diseases 1: 165–169 (1979).

    Article  CAS  Google Scholar 

  • Phillips, I.; King, A.; Warren, C. and Watts, B.: The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae. Journal of Antimicrobial Therapy 2: 31–39 (1976).

    Article  CAS  Google Scholar 

  • Pitt, J.; Siasoco, R.; Kaplan, K. and Weinstein, L.: Antimicrobial activity and pharmacological behavior of cephaloglycin. Antimicrobial Agents and Chemotherapy 630–635 (1967).

  • Quinn, E.L.; Pohloh, D.; Madhavan, T.; Burck, K.; Fisher, E. and Cox, F.: Clinical experience with cefazolin and other cephalosporins in bacterial endocarditis. Journal of Infectious Diseases 128 (Suppl.): 386–391 (1973).

    Article  Google Scholar 

  • Quintiliani, R. and Nightingale, C.H.: Diagnosis and treatment: Drugs five years later —cefazolin. Annals of Internal Medicine 89: 650–656 (1978).

    PubMed  CAS  Google Scholar 

  • Rahal, J.J., Jr.; Meyers, B.R. and Weinstein, L.: Treatment of bacterial endocarditis with cephalothin. New England Journal of Medicine 279: 1305–1309 (1968).

    Article  PubMed  Google Scholar 

  • Ratzan, K.R.; Ruiz, C. and Irvin, G.L.: Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease. Antimicrobial Agents and Chemotherapy 6: 462–431 (1974).

    Article  Google Scholar 

  • Regamey, C.; Libke, R.D.; Engelking, E.R.; Clarke, J.T. and Kirby, W.M.M.: Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. Journal of Infectious Diseases 131: 291–294 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Ribner, B.S.; Billiard, B.S. and Freimer, E.H.: Clinical evaluation of cefatrizine in 101 patients. Current Therapeutic Research 24: 614–621 (1978).

    Google Scholar 

  • Ribner, B.S.; Billiard, B.S. and Freimer, E.H.: Treatment of significant bacterial infections in adults with cefoxitin. Reviews of Infectious Diseases 1: 152–157 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Robson, H.G. and Bowmer, M.I.: Treatment of pneumonia and other serious bacterial infections with cephapirin. Antimicrobial Agents and Chemotherapy 6: 274–281 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Sanders, W.E., Jr.; Johnson, J.E., III. and Taggart, J.G.: Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses. New England Journal of Medicine 290: 424–429 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Santella, P.J.; Tanrisever, B. and Berman, E.: An overview of results of world-wide clinical trials with cefadroxil. Journal of International Medical Research 6: 441–451 (1978).

    PubMed  CAS  Google Scholar 

  • Scholand, J.F.; Hodges, G.R.; Fass, R.J. and Saslaw, S.: Clinical evaluation of cephradine, a new oral cephalosporin. American Journal of Medical Sciences 267: 111–116 (1974).

    Article  CAS  Google Scholar 

  • Schrogie, J.J.; Davies, R.O.; Yeh, K.C.; Rogers, D.; Holmes, G.I.; Skeggs, H. and Martin, C.M.: Bioavailability and pharmacokinetics of cefoxitin sodium. Journal of Antimicrobial Chemotherapy 4 (Suppl. B): 69–78 (1978).

    PubMed  CAS  Google Scholar 

  • Seneca, H.; Lattimer, J.K.; Reilly, M. and Peer, P.: Cephalothin in cystoscopy and retrograde pyelography. Journal of Urology 94: 489–491 (1965).

    PubMed  CAS  Google Scholar 

  • Seneca, H.; Peer, P. and Warren, B.: Treatment of urinary tract infections with cephaloridine. Journal of Urology 97: 154–155 (1967).

    Google Scholar 

  • Shadomy, S.; Wagner, G. and Carver, M.: In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria. Antimicrobial Agents and Chemotherapy 12: 609–613 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Shemonsky, N.K.; Carrizosa, J. and Levison, M.E.: In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalosporin antibiotic. Antimicrobial Agents and Chemotherapy 8: 679–683(1975).

    Article  PubMed  CAS  Google Scholar 

  • Sheng, K.T.; Huang, N.N. and Promadhattavedi, V.: Serum concentrations of cephalothin in infants and children and placental transmissions of the antibiotic. Antimicrobial Agents and Chemotherapy 200–206 (1964).

  • Siegel, M.S.; Thompson, S.E.; Perine, P.L.; Brown, S.T.; Reynolds, G. and Thornsberry, C.: Treatment of uncomplicated gonococcal urethritis with cefoxitin: Comparison with penicillin. Reviews of Infectious Diseases 1: 183–187 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Silver, M.S.; Counts, G.W.; Zeleznik, D. and Turck, M.: Comparison of in vitro antibacterial activity of three oral cephalosporins: Cefaclor, cephalexin, and cephradine. Antimicrobial Agents and Chemotherapy 12: 591–596 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Simon, H.J.; Axline, S.G. and Vosti, K.L.: Cephalothin. Its in vitro antibacterial spectrum as studied in a diagnostic laboratory. California Medicine 103: 395–399 (1965).

    PubMed  CAS  Google Scholar 

  • Sosna, J.P.; Murray, P.R. and Medoff, G.: Comparison of the in vitro activities of HR 756 with cephalothin, cefoxitin, and cefamandole. Antimicrobial Agents and Chemotherapy 14: 876–879 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Southern, P.M., Jr. and Sanford, J.P.: Meningococcal meningitis — suboptimal response to cephalothin therapy. New England Journal of Medicine 280: 1163–1165 (1969).

    Article  PubMed  Google Scholar 

  • Stapley, E.O.; Birnbaum, J.; Miller, A.K.; Wallick, H.; Hendlin, D. and Woodruff, H.B.: Cefoxitin and cephamycins: Microbiological studies. Reviews of Infectious Diseases 1: 73–87 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Stewart, G.T.: Cross allergenicity of penicillin G and related substances. Lancet 1: 509–510 (1962).

    Article  PubMed  CAS  Google Scholar 

  • VanLanduyt, H.W. and Pyckavet, M.: In vitro activity of cefotaxime against cephalothin-resistant clinical isolates. Antimicrobial Agents and Chemotherapy 16: 109–111 (1979).

    Article  CAS  Google Scholar 

  • VanWinzum, C.: Clinical safety and tolerance of cefoxitin sodium: An overview. Journal of Antimicrobial Chemotherapy 4 (Suppi. B): 91–104 (1978).

    PubMed  Google Scholar 

  • Waterman, N.G.; Eickenberg, H.U. and Scharfenberger, L.: Concentration of cefamandole in serum interstitial fluid, bile, and urine. Antimicrobial Agents and Chemotherapy 10: 733–735-(1976).

    Article  PubMed  CAS  Google Scholar 

  • Webb, D.; Thadepalli, H. and Bach, V.: Cefoxitin therapy for bacterial endocarditis. Reviews of Infectious Diseases 1: 170–174 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Weinstein, L.: The cephalosporins: Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection. Annals of Internal Medicine 72: 729–739 (1970).

    PubMed  CAS  Google Scholar 

  • Weinstein, L.: Panel discussion of severe Gram-positive infections. Postgraduate Medical Journal 47 (Suppl. Feb): 94–102 (1971).

    PubMed  Google Scholar 

  • Weinstein, M.P. and Eickhoff, T.C.: Clinical evaluation of cefoxitin in the treatment of respiratory tract and other acute bacterial infections. Reviews of Infectious Diseases 1: 158–164 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Wick, W.E.: Influence of antibiotic stability on the results of in vitro testing procedures. Journal of Bacteriology 87: 1162–1170 (1964).

    PubMed  CAS  Google Scholar 

  • Wick, W.E.: Cephalexin, a new orally absorbed cephalosporin antibiotic. Applied Microbiology 15: 765–769 (1967).

    PubMed  CAS  Google Scholar 

  • Wiesner, P.; MacGregor, R.; Bear, D.; Berman, S.; Holmes, K. and Turck, M.: Evaluation of a new cephalosporin antibiotic, cephapirin. Antimicrobial Agents and Chemotherapy 1: 303–309 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Windorfer, A. and Gasteiger, U.: Studies on serum and cerebrospinal fluid levels of cephacetrile in neonates. Infection 5: 242–247 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Wise, R.; Andrews, J.M. and Bedford, K.A.: LY127935, a novel oxa-β-lactam: An in vitro comparison with other β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 16: 341–345 (1979).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Disease, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio, 44106, USA

    Allan J. Weinstein

Authors
  1. Allan J. Weinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weinstein, A.J. The Cephalosporins: Activity and Clinical Use. Drugs 20, 137–154 (1980). https://doi.org/10.2165/00003495-198020020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198020020-00007

Keywords

Search

Navigation